Sign In
Buy SMMNY
$19.41
-0.370 (-1.87%)
At Close: Jun 03, 2026
Siemens Healthineers AG (SEMHF) Q3 2024 Earnings Call Transcript
07:21am, Wednesday, 31'st Jul 2024
Siemens Healthineers AG (OTCPK:SEMHF) Q3 2024 Earnings Conference Call July 31, 2024 2:30 AM ET Company Participants Marc Koebernick - Head-Investor Relations Bernd Montag - Chief Executive Officer Jo
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "AI in Medical Diagnostics Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.
Siemens Healthineers: The Upside Is Clear To Me Over The Long Term
10:00am, Friday, 05'th Jul 2024
Siemens Healthineers reported good revenue growth and margin expansion in Q2 2024, with strong performance in Imaging, Varian, and Advanced Therapies segments. Despite a recent decline in share price,
Siemens Healthineers: Softer Orders A Risk, But The Story Remains Sound
06:19am, Wednesday, 03'rd Jul 2024
Healthcare capex demand has supported healthy order growth at Siemens Healthineers, as the company leverages new innovative platforms in Imaging (MRI, CT) and radiation oncology (Varian). The Street w
Siemens Healthineers (SHL) 2024 Product Pipeline Analysis and Ongoing Clinical Trails Insights
09:05am, Monday, 10'th Jun 2024
Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Siemens Healthineers AG (SHL) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering. This report
Siemens Healthineers AG (SEMHF) Q1 2024 Earnings Call Transcript
05:11pm, Tuesday, 07'th May 2024
Siemens Healthineers AG (OTCPK:SEMHF) Q1 2024 Results Conference Call May 7, 2024 2:30 AM ET Company Participants Marc Koebernick - IR Bernhard Montag - CEO Jochen Schmitz - CFO Conference Call Partic
Siemens Healthineers Q2 revenue slightly misses expectations, faces headwinds in China
05:44am, Tuesday, 07'th May 2024
German health technology company Siemens Healthineers reported on Tuesday second-quarter revenue growth slightly below consensus expectations, as it was hurt by declining revenue in China.
TAMPA, Fla.--(BUSINESS WIRE)--Enable Me, a VELA Medical company, today cited major new research by Siemens Healthineers entitled, “The future of Mammography: 4 critical challenges,” which cites po
Siemens Healthineers: Good Return, Long-Term Potential Intact
01:30am, Monday, 11'th Mar 2024
Siemens Healthineers has seen a 7.5% increase in its stock price since the last article and has a solid upside potential. The company's recent results show strong revenue growth, margin improvements,
Siemens Healthineers AG (SEMHF) Q1 2024 Earnings Call Transcript
11:12pm, Thursday, 01'st Feb 2024
Siemens Healthineers AG (SEMHF) Q1 2024 Earnings Call Transcript
Siemens Healthineers Q1 sales beat expectations on strong Varian unit
01:26am, Thursday, 01'st Feb 2024
German medical equipment maker Siemens Healthineers on Thursday posted first-quarter revenue above expectations and an operating result in line with consensus, driven by its U.S. cancer treatment unit
Siemens Healthineers: Strong Return, Still A 'Buy'
11:28pm, Sunday, 10'th Dec 2023
Siemens Healthineers reported strong 4Q23 results with revenue growth of 11% and adjusted EBIT growth of 16%. The company aims to achieve double-digit EPS growth by 2025 and beyond through expansion i
Siemens Healthineers AG (SEMHF) Q4 2023 Earnings Call Transcript
09:19am, Thursday, 09'th Nov 2023
Siemens Healthineers AG (OTCPK:SEMHF) Q4 2023 Earnings Conference Call November 8, 2023 2:00 AM ET Company Participants Marc Koebernick - Investor Relations Bernd Montag - Chief Executive Officer Joch
Siemens Healthineers CEO: Will grow business by 6-8% in the next year
05:31am, Wednesday, 08'th Nov 2023
Bernd Montag, CEO of Siemens Healthineers, says the company expects double digit growth in the years to come.
Siemens Healthineers posts forecast beating Q4 results
01:06am, Wednesday, 08'th Nov 2023
Siemens Healthineers on Wednesday posted better than expected fourth-quarter results helped by its cancer care unit and proposed an unchanged dividend for its fiscal year 2023.
